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FAQs About the Antibiotic Resistance Healthcare-
Associated Infections Patient Safety Atlas 
Below are a series of questions about the Antibiotic Resistance (AR) Healthcare-
Associated Infections (HAI) Patient Safety Atlas. Additional questions can be emailed to 
HIP@cdc.gov.  
1. It looks like a particular state/territory/district has a very high percent resistance 
in the Atlas. Does this mean that they have a lot of antibiotic resistance? 
Answer: Not necessarily. It is likely that regions with high percent resistance also have lot of antibiotic resistant infections, but 
additional data are needed before this conclusion can be made. First, while the Atlas data show that antibiotic-resistant bacteria 
are playing a role in HAIs, the main metric (percent resistance or %R) only shows the proportion of bacteria causing CAUTI, 
CLABSI, and SSI infections reported to NHSN that are resistant. There are other types of healthcare-associated infections to 
consider, so this metric does not reflect total burden or a total count of all resistant infections. Second, because percent resistance 
is calculated as a proportion, it is possible that a low number of resistant infections (e.g., 10) can produce a high %R if the total 
number of infections from the bacteria, regardless of resistance traits, are also low (e.g., 20). This means that while percent 
resistance may be “high” in one area, it may not mean that more people are getting resistant infections compared to another 
area. The Atlas does show, however, that resistant bacteria—some of which are ranked as urgent or serious threats—are still 
occurring in healthcare settings and, therefore, are at risk of spreading. Thus, the metrics in the Atlas may best be used as 
indicators of which type of antibiotic resistance problem may be most pressing and worthy of further investigation. 
• For more information regarding the total burden of disease from antibiotic-resistant organisms (HAI or not) in the United 
States, please refer to the Antibiotic Resistance Threats report from 2013. 
• For more information regarding the incidence of healthcare-associated infections, please refer to the latest National and 
State Healthcare-Associated Infections progress report. 
 
2. Where can I learn more about the definitions for antibiotic resistance used in the Atlas?  
Answer: Please see our Phenotype Definitions document, which includes definitions of antibiotic resistance used in Atlas. 
 
3. Which Surgical Site Infections (SSI) are displayed in the Atlas? 
Answer: The Atlas includes all surgical site infections following inpatient procedures reported to NHSN. Additional information on 
the burden of specific surgical site infections can be found in the most recent National and State Healthcare-Associated Infections 
progress report. More information about SSIs collected by NHSN can be found on the NHSN website: 




4. Where can I learn more about the types of infections included in the Atlas, or details about how the summary measures for 
antibiotic resistance are calculated? 
Answer: More information on the types if infections and summary measures reflected in the Atlas data can be found in out 
Methodology document.  
 
5. It looks like there are changes in the percent resistance over time. Does this mean that antibiotic resistance is increasing or 
decreasing? 
Answer: Please see our Summary of Results document for information on changes in resistance over time and our Methodology 
document to understand why caution is advised when comparing resistance data between years. 
 
6. Are antibiotic resistance data in the Atlas confirmed by CDC laboratories? Does the Atlas account for changes in Clinical & 
Laboratory Standards Institute (CLSI) breakpoints over time? 
Answer: The Atlas presents antibiotic resistance data as they are reported to NHSN. These data represent the results of 
laboratory testing performed by each healthcare facility, and are therefore based on the breakpoints used by each facility’s 
laboratory at the time the antimicrobial testing was completed. 
 
7. I am interested in using the Atlas data for my own analysis. What are the limitations to using and interpreting this data?  
Answer: The Atlas intends to make NHSN data easily accessible and we encourage further exploration. Before conducting your 
own analysis, however, please see the “Limitations of the Data” section in the Methodology document to fully understand the 
limitations in using this data to understand the burden of antibiotic resistance.  
 
 
Please send other questions via email to HIP@cdc.gov. 
For more information about the AR Atlas, visit: 
http://www.cdc.gov/hai/surveillance
